ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,969Medicare Part D Prescriptions Filled, Including Refills

Rank: 210 out of 1454

$828K Total Retail Price of All Prescriptions

Rank: 158 out of 1454

408 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
1% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 408 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

12% of this provider’s 408 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 12,642 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
LEVOTHYROXINE SODIUM 666 655 1 5
METOPROLOL SUCCINATE 391 376 2 13
AMLODIPINE BESYLATE 377 366 3 2
HYDROCHLOROTHIAZIDE 310 310 4 9
SIMVASTATIN 298 279 5 1
NAMENDA 263 263 6 48
WARFARIN SODIUM 243 231 7 17
DONEPEZIL HCL 234 234 8 29
FUROSEMIDE 232 230 9 6
LISINOPRIL 215 215 10 4
METFORMIN HCL 211 200 11 8
SERTRALINE HCL 196 193 12 26
BENAZEPRIL HCL 192 186 13 57
GABAPENTIN 187 186 14 16
SYNTHROID 182 179 15 25
METOPROLOL TARTRATE 181 181 16 10
ATORVASTATIN CALCIUM 178 155 17 11
HYDROCODONE-ACETAMINOPHEN 177 171 S3 18 7
ZOLPIDEM TARTRATE 176 158 19 19
OMEPRAZOLE 168 168 20 3
DIGOXIN 159 159 21 70
FENOFIBRATE 154 152 22 68
MIRTAZAPINE 149 149 23 53
CRESTOR 147 147 24 22
LOSARTAN POTASSIUM 143 140 25 14
POLYETHYLENE GLYCOL 3350 131 130 26 61
CITALOPRAM HBR 130 124 27 21
CELEBREX 126 125 28 81
TAMSULOSIN HCL 123 123 29 34
MELOXICAM 113 110 30 37
PREDNISONE 107 106 31 36
EXELON 107 107 31 135
POTASSIUM CHLORIDE 106 106 33 15
AMLODIPINE BESYLATE-BENAZEPRIL 102 96 34 65
ATENOLOL 102 102 34 18
RANITIDINE HCL 101 101 36 43
BYSTOLIC 101 99 36 110
FINASTERIDE 100 100 38 94
LANTUS 92 92 39 51
CARVEDILOL 87 82 40 24
TRAZODONE HCL 85 85 41 50
CLOPIDOGREL 83 83 42 32
LISINOPRIL-HYDROCHLOROTHIAZIDE 82 71 43 27
DIOVAN 79 78 44 40
ESCITALOPRAM OXALATE 74 74 45 78
TRIAMTERENE-HCTZ 72 72 46 44
CIPROFLOXACIN HCL 70 70 47 64
ALLOPURINOL 69 69 48 28
ALENDRONATE SODIUM 69 69 48 35
DILTIAZEM 24HR CD 67 67 50 76
EVISTA 66 54 51 136
PLAVIX 65 65 52 45
RAMIPRIL 63 51 53 66
LEVOXYL 62 57 54 84
TRAMADOL HCL 62 62 54 20
CYMBALTA 61 61 56 55
PRAVASTATIN SODIUM 60 60 57 12
DIOVAN HCT 59 59 58 75
ACTOS 59 59 58 90
LATANOPROST 53 53 60 209
ZETIA 53 50 60 69
QUETIAPINE FUMARATE 52 51 62 91
LEVOFLOXACIN 52 52 62 95
TRICOR 51 48 64 134
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 10, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.